Published in Gene Therapy Weekly, June 14th, 1999
Researchers at The University of Texas M.D. Anderson Cancer Center, Houston, said the findings of the Phase I medical study may have a huge impact on future treatments for the disease, especially for men with localized advanced prostate cancer.
The research team, led by Dr. Christopher Logothetis, completed the Phase I study to assess the safety and efficiency of gene transfer to be achieved in patients with prostate cancer. The researchers hypothesized that effective transfer of the p53 gene would result in cancer cell death,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.